Heart FailureNCT07006350
Heart Failure and Therapeutic Education
An observational study of Heart Failure and Health Education, run by Centre Hospitalier de Gonesse at 1 site in France.
Trial summary
This study looks at whether a special program called the Heart Failure Therapeutic Education Unit (UTIC) helps reduce hospital stays for people with heart failure. It is a retrospective study, which means we are looking back at the records of patients who were followed at the UTIC in 2023 and 2024. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Heart Failure, Health Education, Diet, Sodium-Restricted
- How many people
- 104 participants
- Where
- 1 siteFrance
- Study dates
- 24 Mar 2025to 6 Apr 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: Participants will be selected from adult patients diagnosed with heart failure who received care at the Heart Failure Therapeutic Education Unit (UTIC) of the General Hospital (CHG). The population includes patients who were followed by the UTIC during the years 2023 and 2024. Only those who meet the inclusion criteria and do not fall under the exclusion criteria (e.g., minors, non-UTIC patients, or those who oppose the use of their data) will be considered for the study.
Who may be able to join
- Adults (age ≥ 18 years)
- Patients diagnosed with heart failure
- Patients followed in the Heart Failure Therapeutic Education Unit (UTIC) at the General Hospital (CHG)
- Follow-up occurred during the years 2023 or 2024
Who cannot join
- Patients who do not consent to the use of their medical data
- Minors (under 18 years old)
- Patients not followed in the UTIC program
Trial locations and contacts
1 site in 1 country.
About this study
This study looks at whether a special program called the Heart Failure Therapeutic Education Unit (UTIC) helps reduce hospital stays for people with heart failure. It is a retrospective study, which means we are looking back at the records of patients who were followed at the UTIC in 2023 and 2024.
We want to find out two things:
Read more
If patients who followed the UTIC program were hospitalized less often.
If the advice they received-especially about diet-helped improve their condition.
Only adult patients who were treated at the UTIC are included in the study. We will not use data from patients who are under 18, were not treated in UTIC, or did not give permission to use their information.
The study takes place over two weeks, from March 24 to April 6, 2025.
- Conditions
- Heart Failure, Health Education, Diet, Sodium-Restricted, Disease Management, Therapeutics
- Medical subject headings
- Heart Failure, Health Education
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of hospitalizations among patients with heart failure who were followed at the Unité Thérapeutique de l'Insuffisance Cardiaque (UTIC).
Measured: Review of hospital records for patients seen in 2023-2024.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jun 2025
- Study start24 Mar 2025
- Primary completion6 Apr 2025
- Study completion6 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Heart FailureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 104 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier de Gonesse
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07006350
- Sponsor's protocol ID
- 0105_URC
- Status last verified
- May 2025
- First submitted
- 28 May 2025
- Last updated
- 5 Jun 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Heart Failure and Therapeutic Education
- ClinicalTrials.gov ID
- NCT07006350
- Acronym / sponsor ID
- 0105_URC
- Conditions
- Heart Failure, Health Education, Diet, Sodium-Restricted, Disease Management, Therapeutics
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 104 participants (actual)
- Lead sponsor
- Centre Hospitalier de GonesseUniversity, hospital or other
- Study start
- 24 Mar 2025 (actual)
- Primary completion
- 6 Apr 2025 (actual)
- Study completion
- 6 Apr 2025 (actual)
- First posted
- 5 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study looks at whether a special program called the Heart Failure Therapeutic Education Unit (UTIC) helps reduce hospital stays for people with heart failure. It is a retrospective study, which means we are looking back at the records of patients who were followed at the UTIC in 2023 and 2024.
We want to find out two things:
If patients who followed the UTIC program were hospitalized less often.
If the advice they received-especially about diet-helped improve their condition.
Only adult patients who were treated at the UTIC are included in the study. We will not use data from patients who are under 18, were not treated in UTIC, or did not give permission to use their information.
The study takes place over two weeks, from March 24 to April 6, 2025.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Participants will be selected from adult patients diagnosed with heart failure who received care at the Heart Failure Therapeutic Education Unit (UTIC) of the General Hospital (CHG). The population includes patients who were followed by the UTIC during the years 2023 and 2024. Only those who meet the inclusion criteria and do not fall under the exclusion criteria (e.g., minors, non-UTIC patients, or those who oppose the use of their data) will be considered for the study.
Key inclusion criteria (4 listed)
- Adults (age ≥ 18 years)
- Patients diagnosed with heart failure
- Patients followed in the Heart Failure Therapeutic Education Unit (UTIC) at the General Hospital (CHG)
- Follow-up occurred during the years 2023 or 2024
Key exclusion criteria (3 listed)
- Patients who do not consent to the use of their medical data
- Minors (under 18 years old)
- Patients not followed in the UTIC program
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Number of hospitalizations among patients with heart failure who were followed at the Unité Thérapeutique de l'Insuffisance Cardiaque (UTIC).
Time frame: Review of hospital records for patients seen in 2023-2024.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jun 2025.
Related trials for Heart Failure
RecruitingPhase 2/3
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Heart Failure, Left Ventricular Systolic Dysfunction
RecruitingPhase 1/2
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction
Active, not recruiting
Heart Failure Patient Management and Interventions Using Continuous Patient Monitoring Outside Hospitals and Real-world Data
Chronic Heart Failure, Heart Transplant Recipient
Enrolling by invitationObservational study
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
Heart Failure
Not yet recruitingObservational study
Real-world Effectiveness and Safety of Savagen (Sacubitril/Valsartan) in Malaysian HFrEF Patients
Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Heart Failure and Health Education, run by Centre Hospitalier de Gonesse at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of hospitalizations among patients with heart failure who were followed at the Unité Thérapeutique de l'Insuffisance Cardiaque (UTIC). (time frame: Review of hospital records for patients seen in 2023-2024.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2025.